Found: 20
Select item for more details and to access through your institution.
Clinicopathological features and resistance mechanisms in HIP1‐ALK‐rearranged lung cancer: A multicenter study.
- Published in:
- Genes, Chromosomes & Cancer, 2022, v. 61, n. 4, p. 177, doi. 10.1002/gcc.23005
- By:
- Publication type:
- Article
Evaluation and identification of factors related to and gene mutations in colorectal cancer: A meta-analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.559057
- By:
- Publication type:
- Article
A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR -KDD and Response to Afatinib.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00867
- By:
- Publication type:
- Article
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00301-8
- By:
- Publication type:
- Article
Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1-positive non-small cell lung cancer.
- Published in:
- Oncology Letters, 2019, v. 17, n. 3, p. 3466
- By:
- Publication type:
- Article
A Patient With Lung Adenocarcinoma With BRAF Gene Fusion and Response to Vemurafenib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 1, p. 12, doi. 10.1002/cam4.2652
- By:
- Publication type:
- Article
Clonally‐related primary ALK rearranged adenocarcinoma and associated metastatic lesions.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 7, p. 881, doi. 10.1111/1759-7714.12648
- By:
- Publication type:
- Article
CEP72‐ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next‐generation sequencing.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 5, p. 652, doi. 10.1111/1759-7714.12617
- By:
- Publication type:
- Article
Dual drive coexistence of <italic>EML4‐ALK</italic> and <italic>TPM3‐ROS1</italic> fusion in advanced lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 2, p. 324, doi. 10.1111/1759-7714.12578
- By:
- Publication type:
- Article
Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 1, p. 159, doi. 10.1111/1759-7714.12518
- By:
- Publication type:
- Article
Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature review.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 6, p. 714, doi. 10.1111/1759-7714.12496
- By:
- Publication type:
- Article
Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 5, p. 417, doi. 10.1111/1759-7714.12455
- By:
- Publication type:
- Article
The Antitumor Effect of Xihuang Pill on Treg Cells Decreased in Tumor Microenvironment of 4T1 Breast Tumor-Bearing Mice by PI3K/AKT~AP-1 Signaling Pathway.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2018, v. 2018, p. 1, doi. 10.1155/2018/6714829
- By:
- Publication type:
- Article
Prevalence And Clinical Significance Of Oncogenic CD79B And MYD88 Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 10165, doi. 10.2147/OTT.S222189
- By:
- Publication type:
- Article
Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 7821, doi. 10.2147/OTT.S178985
- By:
- Publication type:
- Article
Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Potential mechanism of primary resistance to icotinib in patients with advanced non–small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi‐center study.
- Published in:
- Cancer Science, 2020, v. 111, n. 2, p. 679, doi. 10.1111/cas.14277
- By:
- Publication type:
- Article